Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-08
2005-02-08
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C540S456000
Reexamination Certificate
active
06852729
ABSTRACT:
A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2, 6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
REFERENCES:
patent: 4079128 (1978-03-01), Lin et al.
patent: 4080445 (1978-03-01), Lin et al.
patent: 0 041 795 (1981-12-01), None
patent: 0 329 460 (1989-08-01), None
patent: 0 423 714 (1991-04-01), None
patent: WO 9409010 (1994-04-01), None
patent: WO 9703654 (1997-02-01), None
patent: WO 9804279 (1998-02-01), None
patent: WO 9833482 (1998-08-01), None
Navarro Francois
Petit Samuel
Stone Guy
Kifle Bruck
Novartis AG
Pfeiffer Hesna J.
Savitsky Thomas R.
LandOfFree
Macrolides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrolides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrolides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3447002